When we evaluate a company as an investment candidate, there are many important considerations and our decision process is often more of an "art" than a "science." At the end of the day, the companies we back generally have a significant blend of the following important attributes:

• High integrity, experienced management team with strong track record
• Expansion-stage with clear evidence of initial commercial adoption and growth potential
• Attractive market adoption dynamics
• Demonstrable and compelling ROI propositions
• Clear impact on outcomes, efficiencies and cost reduction within the healthcare continuum
• Substantial barriers to entry
• Attractive business model
• Significant valuation inflection point expected in near to mid-term
• Strong prospects for Radius to leverage its network and experience to impact corporate development